临床试验参与者对基因研究数据在未来研究中再利用的看法

Q4 Pharmacology, Toxicology and Pharmaceutics
R. Devarinti, M. S. Ganachari
{"title":"临床试验参与者对基因研究数据在未来研究中再利用的看法","authors":"R. Devarinti, M. S. Ganachari","doi":"10.2174/0118756921305151240503075928","DOIUrl":null,"url":null,"abstract":"\n\nClinical trial participants play a crucial role in advancing medical\nresearch, and the data generated from their participation can indeed be invaluable for\nfuture studies. However, the reuse of genetic or clinical research data comes with ethical\nchallenges that need careful consideration. Here are some of the key ethical issues associated\nwith the re-use of such data: Reusing data without clear informed consent raises issues\nof autonomy and respect for individuals' choices.\n\n\n\nThe main aim of this study is to assess the understanding of individuals involved\nin clinical trials regarding the sharing of genetic research information. Moreover,\nit seeks to explore the ethical issues and benefits linked with the use of genetic research\ndata for future research initiatives.\n\n\n\nA cross-sectional observational study was applied to assess\nKnowledge Attitude Practices of clinical trial participants on reuse of genetic research data.\n\n\n\nThe majority 70% of clinical trial participants were unsure about the difficulties\nthat may arise in future regarding the re-use of genomic data, with concerns about confidentiality\nbeing the most common.\n\n\n\nThe present study prioritized the involvement of clinical trial participants\ndue to their critical role in both genetic and clinical research endeavors. There is a lack of\nawareness and understanding regarding the re-use of genetic sample data and ethical issues\namong the trial participants. Researchers must take measures to de-identify or anonymize\ndata to protect participants. There is a clear need for comprehensive awareness\nprograms and guidelines aimed at all clinical trial stakeholders. These initiatives would\nensure that researchers, participants, and other involved parties are well-informed and adhere\nto ethical standards when utilizing genetic data for subsequent research endeavors.\n","PeriodicalId":11056,"journal":{"name":"Current Pharmacogenomics and Personalized Medicine","volume":"120 30","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Clinical Trial Participant's Perspectives on Genetic Research Data Re-uses for Future Research\",\"authors\":\"R. Devarinti, M. S. Ganachari\",\"doi\":\"10.2174/0118756921305151240503075928\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\\n\\nClinical trial participants play a crucial role in advancing medical\\nresearch, and the data generated from their participation can indeed be invaluable for\\nfuture studies. However, the reuse of genetic or clinical research data comes with ethical\\nchallenges that need careful consideration. Here are some of the key ethical issues associated\\nwith the re-use of such data: Reusing data without clear informed consent raises issues\\nof autonomy and respect for individuals' choices.\\n\\n\\n\\nThe main aim of this study is to assess the understanding of individuals involved\\nin clinical trials regarding the sharing of genetic research information. Moreover,\\nit seeks to explore the ethical issues and benefits linked with the use of genetic research\\ndata for future research initiatives.\\n\\n\\n\\nA cross-sectional observational study was applied to assess\\nKnowledge Attitude Practices of clinical trial participants on reuse of genetic research data.\\n\\n\\n\\nThe majority 70% of clinical trial participants were unsure about the difficulties\\nthat may arise in future regarding the re-use of genomic data, with concerns about confidentiality\\nbeing the most common.\\n\\n\\n\\nThe present study prioritized the involvement of clinical trial participants\\ndue to their critical role in both genetic and clinical research endeavors. There is a lack of\\nawareness and understanding regarding the re-use of genetic sample data and ethical issues\\namong the trial participants. Researchers must take measures to de-identify or anonymize\\ndata to protect participants. There is a clear need for comprehensive awareness\\nprograms and guidelines aimed at all clinical trial stakeholders. These initiatives would\\nensure that researchers, participants, and other involved parties are well-informed and adhere\\nto ethical standards when utilizing genetic data for subsequent research endeavors.\\n\",\"PeriodicalId\":11056,\"journal\":{\"name\":\"Current Pharmacogenomics and Personalized Medicine\",\"volume\":\"120 30\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-05-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current Pharmacogenomics and Personalized Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2174/0118756921305151240503075928\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Pharmacology, Toxicology and Pharmaceutics\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Pharmacogenomics and Personalized Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/0118756921305151240503075928","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

摘要

临床试验参与者在推动医学研究方面发挥着至关重要的作用,他们参与试验所产生的数据对于未来的研究确实非常宝贵。然而,基因或临床研究数据的再利用也会带来伦理挑战,需要认真考虑。以下是与重复使用此类数据相关的一些关键伦理问题:本研究的主要目的是评估参与临床试验的个人对共享基因研究信息的理解。本研究采用横断面观察法,评估临床试验参与者对基因研究数据再利用的认识和态度。70% 的临床试验参与者对基因组数据再利用将来可能出现的困难表示不确定,其中最常见的是对保密性的担忧。由于临床试验参与者在基因研究和临床研究中都扮演着重要角色,因此本研究优先考虑临床试验参与者的参与。试验参与者对基因样本数据的再利用和伦理问题缺乏认识和了解。研究人员必须采取措施去标识化或匿名化数据,以保护参与者。显然需要针对所有临床试验相关方制定全面的宣传计划和指南。这些举措将确保研究人员、参与者和其他相关方在利用基因数据进行后续研究工作时充分了解情况并遵守伦理标准。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Clinical Trial Participant's Perspectives on Genetic Research Data Re-uses for Future Research
Clinical trial participants play a crucial role in advancing medical research, and the data generated from their participation can indeed be invaluable for future studies. However, the reuse of genetic or clinical research data comes with ethical challenges that need careful consideration. Here are some of the key ethical issues associated with the re-use of such data: Reusing data without clear informed consent raises issues of autonomy and respect for individuals' choices. The main aim of this study is to assess the understanding of individuals involved in clinical trials regarding the sharing of genetic research information. Moreover, it seeks to explore the ethical issues and benefits linked with the use of genetic research data for future research initiatives. A cross-sectional observational study was applied to assess Knowledge Attitude Practices of clinical trial participants on reuse of genetic research data. The majority 70% of clinical trial participants were unsure about the difficulties that may arise in future regarding the re-use of genomic data, with concerns about confidentiality being the most common. The present study prioritized the involvement of clinical trial participants due to their critical role in both genetic and clinical research endeavors. There is a lack of awareness and understanding regarding the re-use of genetic sample data and ethical issues among the trial participants. Researchers must take measures to de-identify or anonymize data to protect participants. There is a clear need for comprehensive awareness programs and guidelines aimed at all clinical trial stakeholders. These initiatives would ensure that researchers, participants, and other involved parties are well-informed and adhere to ethical standards when utilizing genetic data for subsequent research endeavors.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Current Pharmacogenomics and Personalized Medicine
Current Pharmacogenomics and Personalized Medicine Pharmacology, Toxicology and Pharmaceutics-Pharmacology
CiteScore
0.40
自引率
0.00%
发文量
11
期刊介绍: Current Pharmacogenomics and Personalized Medicine (Formerly ‘Current Pharmacogenomics’) Current Pharmacogenomics and Personalized Medicine (CPPM) is an international peer reviewed biomedical journal that publishes expert reviews, and state of the art analyses on all aspects of pharmacogenomics and personalized medicine under a single cover. The CPPM addresses the complex transdisciplinary challenges and promises emerging from the fusion of knowledge domains in therapeutics and diagnostics (i.e., theragnostics). The journal bears in mind the increasingly globalized nature of health research and services.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信